Jacobs Levy Equity Management’s Immunogen Inc IMGN Stock Holding History

Jacobs Levy Equity Management’s Portfolio IMGN Stock Details IMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-94,826	Closed	-$451K	–	1118
2022 Q1	$451K	Sell	94,826 -42,748	-31%	-$203K	﹤0.01%	876
2021 Q4	$1.02M	Buy	137,574 +94,150	+217%	+$699K	0.01%	735
2021 Q3	$246K	Sell	43,424 -29,905	-41%	-$169K	﹤0.01%	958
2021 Q2	$483K	Buy	73,329 +29,905	+69%	+$197K	﹤0.01%	867
2021 Q1	$352K	Sell	43,424 -293,429	-87%	-$2.38M	﹤0.01%	916
2020 Q4	$2.17M	Buy	336,853 +20,752	+7%	+$134K	0.02%	568
2020 Q3	$1.14M	Sell	316,101 -208,336	-40%	-$750K	0.01%	636
2020 Q2	$2.41M	Sell	524,437 -37,193	-7%	-$171K	0.03%	487
2020 Q1	$1.92M	Sell	561,630 -16,384	-3%	-$55.9K	0.02%	482
2019 Q4	$2.95M	Buy	578,014 +152,016	+36%	+$776K	0.03%	472
2019 Q3	$1.03M	Buy	425,998 +305,698	+254%	+$740K	0.01%	611
2019 Q2	$261K	Sell	120,300 -168,840	-58%	-$366K	﹤0.01%	835
2019 Q1	$784K	Buy	289,140 +735	+0.3%	+$1.99K	0.01%	709
2018 Q4	$1.38M	Buy	288,405 +85,198	+42%	+$409K	0.02%	539
2018 Q3	$1.92M	Sell	203,207 -22,657	-10%	-$215K	0.03%	529
2018 Q2	$2.2M	Buy	225,864 +42,530	+23%	+$414K	0.03%	491
2018 Q1	$1.93M	Sell	183,334 -169,190	-48%	-$1.78M	0.03%	490
2017 Q4	$2.26M	Buy	352,524 +15,500	+5%	+$99.4K	0.04%	430
2017 Q3	$2.58M	Sell	337,024 -13,610	-4%	-$104K	0.05%	381
2017 Q2	$2.49M	Buy	+350,634	New	+$2.49M	0.05%	379
2016 Q4	–	Sell	-209,500	Closed	-$561K	–	1076
2016 Q3	$561K	Sell	209,500 -126,100	-38%	-$338K	0.01%	696
2016 Q2	$1.03M	Buy	335,600 +109,700	+49%	+$338K	0.02%	582
2016 Q1	$1.93M	Buy	225,900 +191,200	+551%	+$1.63M	0.04%	417
2015 Q4	$471K	Buy	34,700 +20,200	+139%	+$274K	0.01%	561
2015 Q3	$139K	Sell	14,500 -133,728	-90%	-$1.28M	﹤0.01%	736
2015 Q2	$2.13M	Sell	148,228 -48,200	-25%	-$693K	0.04%	369
2015 Q1	$1.76M	Buy	+196,428	New	+$1.76M	0.03%	385